amino}benzoic acid...](https://static.cymitquimica.com/products/3D/img/VCA84448.png "Haga clic para ampliar")
Methotrexate related compound E (4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
CAS: 70844-48-3
Ref. 3D-VCA84448
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
Methotrexate is a drug that is used to treat autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease. It is also used to treat cancer, including urothelial carcinoma, and some forms of leukemia. Methotrexate inhibits the production of immune cells by binding to folic acid receptors in lymphocytes. Methotrexate-related compound E (MTCE) is a methotrexate analog with immunosuppressive activity. MTCE binds to the folate receptor in a similar manner to methotrexate, but does not inhibit dihydrofolate reductase like methotrexate does. This means that MTCE has lower toxicity than methotrexate because it does not interfere with DNA synthesis or repair as much as methotrexate does.
MTCE has been shown to decrease disease activity in vivo models of autoimmune diseases and bowel disease. The molecule was found to be non-toxic in
Propiedades químicas
Consulta técnica sobre: 3D-VCA84448 Methotrexate related compound E (4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
